• 

  Why Is This New Generation of Alzheimer’s Drugs Such a Big Deal?
• 

  On the Verge of Full FDA Approval, New Details About Leqembi Death
• 

  Filling the Void: The Race to Treat Later-Stage Alzheimer’s
• 

  Respiratory Infections Like Flu Appear to Triple Alzheimer’s Risk
• 

  In Alzheimer’s, Hallucinations Signal Faster Cognitive Decline
• 

  Please Don’t Stop the Music: 3 Ways to Use Music As Therapy Dementia Care
• 

  Does Neuriva Plus Work? A Settled Lawsuit Bars Its Makers From Claiming It Does
• 

  Getting Mono May Make You 32 Times More Likely to Develop M.S.
• 

  Tony Gonzales’s Fight for Better Alzheimer’s Care in the U.S. Hispanic Community
• 

  Do Serine Supplements Work? Study Says ‘Exercise Caution’
• 

  For Some Vets With Alzheimer’s, VA to Help Pay for New Drug Leqembi
• 

  These Lesser-Known Toxic Proteins Are Found in 60% of Alzheimer’s Cases
• 

  Severe Viral Infections Raise Risk of Alzheimer’s, MS and Parkinson’s
• 

  After 10 Years of Alzheimer’s Clinical Trials, Eli Lilly’s Solanezumab Fails
• 

  How Hearing Aids Can Reduce Alzheimer’s Dementia Risk

Previous192021Next